Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia

Juliane Bubeck Wardenburg1, Ravi J Patel, Olaf Schneewind

  • 1Department of Microbiology, University of Chicago, 920 E. 58th St., Chicago, IL 60637, USA.

Infection and Immunity
|November 15, 2006
PubMed

Insights

Researchers developed a mouse model for Staphylococcus aureus pneumonia that mirrors human disease. This model revealed that S. aureus surface proteins and toxins contribute to pneumonia mortality.

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Background:

  • Staphylococcus aureus is a significant cause of bacterial pneumonia.
  • Understanding the mechanisms of S. aureus pneumonia is crucial for developing effective treatments.
  • Existing models may not fully recapitulate human disease features.

Purpose of the Study:

  • To establish and validate a mouse model of Staphylococcus aureus-induced pneumonia.
  • To investigate the contribution of S. aureus virulence factors to pneumonia pathogenesis and mortality.

Main Methods:

  • Induction of pneumonia in adult, immunocompetent C57BL/6J mice using Staphylococcus aureus.
  • Characterization of clinical and pathological features of the induced pneumonia.
  • Assessment of the role of S. aureus strain Newman surface proteins and secreted exotoxins in mortality.

Main Results:

  • The developed mouse model closely mimics human pneumonia clinically and pathologically.
  • S. aureus strain Newman surface proteins were identified as key contributors to pneumonia.
  • Secreted exotoxins from S. aureus were also found to play a significant role in pneumonia-related mortality.

Conclusions:

  • The established mouse model is a valuable tool for studying Staphylococcus aureus pneumonia.
  • Surface proteins and secreted exotoxins of S. aureus are critical determinants of pneumonia-induced mortality.
  • Further research can utilize this model to explore therapeutic strategies against S. aureus pneumonia.

Related Concept Videos

Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...